Evidence map›Paper›PMID 25887621›Full record

ReviewItalian journal of pediatrics2015

Antimicrobial therapy in neonatal intensive care unit.

Chryssoula Tzialla, Alessandro Borghesi, Gregorio Serra, Mauro Stronati, Giovanni Corsello

Open access · goldAbstract readReview
In one paragraph

Review in Italian journal of pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 4 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 4 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Antibiotic regimens for early-onset neonatal sepsis.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Inadequate use of antibiotics and increase in neonatal sepsis caused by resistant bacteria related to health care assistance: a systematic review.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Pooled it
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Observational
  15. Article
  16. Retrospective Study onAntibiotics (Basel, Switzerland) · 2023
    Article
  17. Ceftazidime-Avibactam Treatment forAntibiotics (Basel, Switzerland) · 2023
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chryssoula TziallaNeonatologia, Patologia Neonatale e Terapia Intensiva neonatale, Fondazione IRCCS Policlinico San Matteo, Piazzale Golgi 19, 27100, Pavia, Italy. c.tzialla@smatteo.pv.it.
Alessandro BorghesiNeonatologia, Patologia Neonatale e Terapia Intensiva neonatale, Fondazione IRCCS Policlinico San Matteo, Piazzale Golgi 19, 27100, Pavia, Italy. alessandroborghesi@yahoo.it.
Gregorio SerraTerapia Intensiva Neonatale Dipartimento di Scienze per la Promozione della Salute e Materno Infantile "G. D'Alessandro", Università degli Studi di Palermo, Via Alfonso Giordano, 390127, Palermo, Italy. gregorio.serra@alice.it.
Mauro StronatiNeonatologia, Patologia Neonatale e Terapia Intensiva neonatale, Fondazione IRCCS Policlinico San Matteo, Piazzale Golgi 19, 27100, Pavia, Italy. m.stronati@smatteo.pv.it.
Giovanni CorselloTerapia Intensiva Neonatale Dipartimento di Scienze per la Promozione della Salute e Materno Infantile "G. D'Alessandro", Università degli Studi di Palermo, Via Alfonso Giordano, 390127, Palermo, Italy. giovanni.corsello@unipa.it.
Policlinico San Matteo Fondazione · ITUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe infections represent the main cause of neonatal mortality accounting for more than one million neonatal deaths worldwide every year. Antibiotics are the most commonly prescribed medications in neonatal intensive care units (NICUs) and in industrialized countries about 1% of neonates are exposed to antibiotic therapy. Sepsis has often nonspecific signs and symptoms and empiric antimicrobial therapy is promptly initiated in high risk of sepsis or symptomatic infants. However continued use of empiric broad-spectrum antibiotic treatment in the setting of negative cultures especially in preterm infants may not be harmless.The benefits of antibiotic therapy when indicated are clearly enormous, but the continued use of antibiotics without any microbiological justification is dangerous and only leads to adverse events. The purpose of this review is to highlight the inappropriate use of antibiotics in the NICUs, to exam the impact of antibiotic treatment in preterm infants with negative cultures and to summarize existing knowledge regarding the appropriate choice of antimicrobial agents and optimal duration of therapy in neonates with suspected or culture-proven sepsis in order to prevent serious consequences.

Indexed as

Anti-Bacterial AgentsAntibiotic ProphylaxisGlobal HealthHumansInfant, NewbornInfant, Newborn, DiseasesIntensive Care Units, NeonatalAnti-Bacterial Agents

Identifiers

PMID25887621
PMCPMC4410467
OpenAlexW2106164056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.